Page last updated: 2024-09-03

tazobactam and nxl 104

tazobactam has been researched along with nxl 104 in 3 studies

Compound Research Comparison

Studies
(tazobactam)
Trials
(tazobactam)
Recent Studies (post-2010)
(tazobactam)
Studies
(nxl 104)
Trials
(nxl 104)
Recent Studies (post-2010) (nxl 104)
1,327153694705

Protein Interaction Comparison

ProteinTaxonomytazobactam (IC50)nxl 104 (IC50)
Peptidoglycan D,D-transpeptidase MrdAEscherichia coli K-120.59

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Barraja, P; Carbone, A; Cascioferro, S; Cirrincione, G; Diana, P; Montalbano, A; Parrino, B; Schillaci, D; Spanò, V1
Martin, NI; Tehrani, KHME1
Colchón, E; González-Bello, C; Pernas, M; Rodríguez, Á; Rodríguez, D1

Reviews

2 review(s) available for tazobactam and nxl 104

ArticleYear
β-lactam/β-lactamase inhibitor combinations: an update.
    MedChemComm, 2018, Sep-01, Volume: 9, Issue:9

    Topics:

2018
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Humans; Protein Structure, Secondary; Protein Structure, Tertiary; Treatment Outcome

2020

Other Studies

1 other study(ies) available for tazobactam and nxl 104

ArticleYear
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.
    Journal of medicinal chemistry, 2017, 10-26, Volume: 60, Issue:20

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Imipenem; Pseudomonas Infections

2017